Purple Biotech Ltd. (PPBT)

Purple Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	5.24	6.28	6.11	6	4.39
Research & Development	17.03	16.32	11.83	7.24	2.28
Operating Expenses	22.27	22.6	17.93	13.24	6.67
Operating Income	-22.27	-22.6	-17.93	-13.24	-6.67
Interest Expense / Income	2.2	0.07	0.21	0.06	0.18
Other Expense / Income	-44.35	-44.34	-36.53	-41.3	-12.92
Pretax Income	19.88	21.67	18.38	28	6.07
Income Tax	0	0	0	0	0.22
Net Income	19.88	21.67	18.38	28	5.85
Net Income Growth	-8.25%	17.86%	-34.34%	378.62%	12.50%
Shares Outstanding (Basic)	198	178	18	12	2
Shares Outstanding (Diluted)	-	-	18	12	2
Shares Change	11.37%	913.93%	52.76%	493.78%	36.34%
EPS (Basic)	-9.00	-12.00	-10.10	-25.00	-27.50
EPS (Diluted)	-9.00	-12.00	-10.10	-25.00	-27.50
Free Cash Flow	-19.93	-16.96	-15.37	-12.25	-5.59
Free Cash Flow Per Share	-1.00	-0.95	-8.75	-10.65	-28.87
Effective Tax Rate	-	-	-	-	3.56%
EBITDA	22.27	21.94	18.83	28.3	6.43
Depreciation & Amortization	0.2	0.2	0.23	0.24	0.18
EBIT	22.08	21.74	18.6	28.06	6.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).